Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Alpha1A/1L-adrenoceptor agonists disclosed for urinary incontinence, etc.

Oct. 1, 1999

Preclinical study results support potential of NK1 antagonist in treating micturition disorders

Sep. 23, 1999

Ortho-McNeil designs new prostate-selective alpha1a-adrenoceptor antagonists

Sep. 15, 1999

Synaptic and Merck & Co. discontinue development of oral treatment for BPH

Sep. 13, 1999

Wider therapeutic index predicted for Ditropan XL compared to conventional Ditropan

Sep. 10, 1999

NexMed reports progress with topical treatments for sexual dysfunction

Sep. 9, 1999

FibroGen and Taisho to collaborate on kidney fibrosis research

Sep. 8, 1999

YM-31758: a potent and selective inhibitor of human prostatic 5alpha-reductase

Sep. 6, 1999

New treatment for urinary incontinence in the Recordati pipeline

Aug. 31, 1999

Long-term continuation rate good for Alza's overactive bladder therapy

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.